Address And Details

82 Devonshire St , Boston, MA 02109
Fund Manager Guillermo de las Casas
Manager Tenure 11 Years 5 Months

Strategy And Objective

The Fund seeks capital appreciation. The Adviser normally invests the fund's assets primarily in non-U.S. securities. The Adviser normally invests the fund's assets primarily in common stocks. The Adviser normally invests at least 80% of the fund's assets in securities of companies principally engaged in the real estate industry and other real estate related investments. Companies in the real estate industry and real estate related investments may include, for example, real estate investment trusts (REITs) or similar REIT-like entities that either own properties or makeconstruction or mortgage loans, real estate developers, companies with substantial real estate holdings, and other companies whose products and services are related to the real estate industry, such as building supply manufacturers, mortgage lenders, or mortgage servicing companies. The Adviser normally allocates the fund's investments across different countries and regions. Because the fund is classified as non-diversified, the Adviser may invest a significant percentage of the fund's assets in a single issuer. In buying and selling securities for the fund, the Adviser relies on fundamental analysis, which involves a bottom-up assessment of a company's potential for success in light of factors including its financial condition, earnings outlook, strategy, management, industry position, and economic and market conditions. If the Adviser's strategies do not work as intended, the fund may not achieve its objective.Equity securities represent an ownership interest, or the right to acquire an ownership interest, in an issuer. Different types of equity securities provide different voting and dividend rights and priority in the event of the bankruptcy of the issuer. Equity securities include common stocks, preferred stocks, convertible securities, and warrants.

Net Asset Value

as of 5:22 PM ET 09/17/2021

Performance

  • 1 Week
  • -1.32%
  • 1 Month
  • -5.08%
  • 3 Months
  • -1.86%
  • 1 Yr Return
  • +15.62%
  • 5 Yr Return
  • +44.12%

Equity Sector Breakdown

Finance 69.26%
Technology 3.75%
RetailTrade 2.60%
ConsumerDurables 0.86%
NonDurables 0.67%
IndustrialCyclical 0.53%
Services 0.49%
Energy n/a
Health n/a
Utilities n/a

Asset Allocation

Asset Type % Of Allocation
Stocks 95.21%
ForeignStocks 89.97%
Cash 0.00%
Bonds 0.00%
Preferred 0.00%
Convertible 0.00%
Other 0.00%
ForeignBonds 0.00%
ForeignHedged 0.00%
Total Net Assets 17.36 M

Risk Measures

Criteria 3 Years 5 Years 10 Years
Alpha 0.38 -0.62 -2.18
Beta 0.67 0.65 0.79
R Squared 0.69 0.60 0.53
Std Deviation 15.02 12.67 14.46
Sharpe Ratio 0.85 0.85 n/a

Purchase Information

as of 5:17 PM ET 09/16/2021
Minimum Initial $0
Minimum Additional $0
Minimum Initial IRA $0

Performance

Timeframe Average Annual Current Performance Monthly As Of 08/31/2021 Average Annual Current Performance Quarterly As Of 06/30/2021 Avg Annual Current Performance Monthly As Of 08/31/2021 Avg Annual Current Performance Quarterly As Of 06/30/2021
1 Year
  • +26.28%
  • +28.82%
+26.28% +28.82%
3 Year
  • +12.63%
  • +10.62%
+12.63% +10.62%
10 Year
  • +9.99%
  • +8.38%
+9.99% +8.38%
Life Of Fund
  • +3.13%
  • +2.77%
+3.13% +2.77%

Top 10 Holdings

Symbol Company Name % Of Assets
VNA:GR VONOVIA SE 6.43%
1113 CK ASSET HOLDINGS LTD 5.42%
MITEY MITSUBISHI ESTATE CO LTD 4.99%
IRES.I IRISH RESIDENTIAL PROPERTIES 3.43%
3269.T ADVANCE RESIDENCE INVESTMENT 3.32%
LEGn.DE LEG IMMOBILIEN AG 2.57%
3231:JP NOMURA REAL ESTATE 2.57%
SGLA SINO GREEN LAND CORPORATION 2.30%
W05:SP WING TAI HOLDINGS LTD 2.21%
PSPN.S PSP SWISS PROPERTY AG 1.97%

Recent Articles from TheStreet

Chinese Investors Mock Asset Managers And Offer Advice On Stock Picks For Cautious Approach To Renewables Sector

Stocks May Drop 20% as Stimulus Eases, Growth Slows: Morgan Stanley

Stocks could drop 20% as fiscal stimulus is withdrawn and economic growth slows, a Morgan Stanley strategist says.

AstraZeneca Takeover Chatter Bubbles Up Again After Massive Drug Trial Disappointment

AstraZeneca Stock Rises on Progress With Breast-Cancer Treatment

AstraZeneca's breast-cancer treatment reduced the risk of disease progression or death by 72% vs. a currently approved treatment.

Cryptocurrency Lead

Cryptocurrency Price Check: Bitcoin Tumbles on Evergrande Woes

Bitcoin and other cryptocurrencies are battered as China Evergrande Group struggles with bond obligations.

China Aims To Strengthen Its Semiconductor Supply Chain With New Standards Group That Includes Huawei, SMIC

Brooks Automation Stock Jumps on Plan to Sell Chip Solutions Unit for $3B

Brooks Automation is selling its chip solutions group and said it would no longer pursue splitting into two companies.

DR Horton, Verizon, HCA Holdings Top Analysts' Actions Monday

DR Horton Trims 2021 Sales Forecast Amid Supply Chain Disruptions

DR Horton said "significant disruptions in the supply chain ... along with tightness in the labor market" will lead to a modestly lower full-year sales forecast.

11. Colgate-Palmolive

Colgate-Palmolive Underappreciated, Deutsche Bank Says, Lifting to Buy

Colgate-Palmolive stock was upgraded to buy with an $86 price target at Deutsche Bank.

Watch Jim Cramer Live 9/20

Video: Jim Cramer on the Market Selloff, Evergrande, Debt Ceiling, Fed, Pfizer

Jim Cramer discusses the market selloff, Evergrande, debt ceiling talks, the upcoming Federal Reserve meeting, Pfizer and more in his latest video interview with TheStreet.

Wynn Lead

Wynn Resorts 'Worth Risk' of Macau Restrictions, Morgan Stanley Says

Wynn Resorts faces regulatory uncertainty in Macau, but Morgan Stanley says the casino operator is still 'worth the risk.'

Chinese Tesla Challenger Xpeng Prices Its P5 Sedan From US$24,700 After Subsidies As Battle For EV Buyers Intensifies

Tesla Wider Self-Driving Effort Reportedly Opposed by NTSB Chief

Tesla wants to expand its autonomous-driving effort to help cars make their way through cities, not just highways.

BioNTech and Pfizer's mRNA-based vaccine candidate BNT162b2 has proven to be more than 90 per cent effective in preventing Covid-19 infections. Photo: Reuters

Premarket Movers Monday - Pfizer, Netflix, Li Auto, AstraZeneca

Stocks moving in premarket trading Monday include Pfizer, Netflix, Li Auto, AstraZeneca and Bank of America.